Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series

by A. Stabile, N. Fossati, E. Zaffuto, G. Gandaglia, D. Robesti, D. Cannoletta, M. Menean, E. Mazzone, S. Comana, V. Cucchiara, G. Fallara, V. Cucchiara, P. Dell’oglio, A. Martini, M. Moschini, A. Rizzo, V. Mirone, A. Necchi, A. Salonia, P.I. Karakiewicz, F. Montorsi, F. De Cobelli, A. Briganti
Published 2020-07-01

When to omit lymphadenectomy during radical prostatectomy in patients with clinical localized prostate cancer: A clinical net benefit analysis weighting staging accuracy, risk of m...

by A. Larcher, G. Gandaglia, N. Fossati, S. Scuderi, F. Barletta, D. Robesti, V. Cucchiara, F. Muttin, G. Rosiello, A. Stabile, U. Capitanio, A. Salonia, F. Montorsi, A. Briganti
Published 2020-07-01

Association between BRCA 1/2 polymorphisms and disease aggressiveness in a prospective cohort of prostate cancer patients undergoing radical prostatectomy

by V. Cucchiara, D. Lazarevic, D. Cittaro, M. Zoccolillo, M. Bianchi, N. Longo, S. Scuderi, F. Barletta, G. Gandaglia, N. Fossati, V. Mirone, F. Montorsi, G. Tonon, A. Briganti
Published 2020-07-01

Is focal ablation as effective as hemi-ablation? Analysis of treatment patterns over 12 years from a high volume centre for focal therapy

by A. Stabile, G. Gandaglia, N. Fossati, G. Sorce, S. Scuderi, G. Fallara, V. Cucchiara, E. Zaffuto, D. Robesti, F. Pellegrino, C. Orczyk, F. Giganti, H.U. Ahmed, M. Emberton, A. Briganti, F. Montorsi, C.M. Moore
Published 2020-07-01

Association between BRCA 1/2 polymorphisms and disease aggressiveness in a prospective cohort of prostate cancer patients undergoing radical prostatectomy

by V. Cucchiara, D. Lazarevic, D. Cittaro, M. Zoccolillo, M. Bianchi, N. Longo, S. Scuderi, F. Barletta, A. Martini, E. Mazzone, G. Basile, G.O. Cirulli, D. Cignoli, M. Tutolo, N. Fossati, G. Gandaglia, V. Mirone, F. Montorsi, G. Tonon, A. Briganti
Published 2020-10-01

The implementation of a prospective standardized postoperative complication system according to the EAU guidelines is associated with a decrease in the rate of adverse postoperativ...

by G. Rosiello, N. Fossati, G. Gandaglia, V. Cucchiara, L. Nocera, E. Zaffuto, S. Scuderi, F. Barletta, D. Robesti, V. Mirone, N. Longo, A. Rizzo, D. Cannoletta, E. Zito, A. Gallina, F. Deho’, S. Comana, A. Stabile, C. Bravi, N. Suardi, F. Montorsi, A. Briganti
Published 2020-07-01

Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches

by A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, F. Barletta, S. Scuderi, V. Cucchiara, D. Robesti, M. Menean, G. Rosiello, C.A. Bravi, P. Dell’Oglio, A. Martini, A. Salonia, G. Brembilla, A. Esposito, F. Montorsi, F. De Cobelli, A. Briganti
Published 2020-07-01

Is focal ablation as effective as hemi-ablation? analysis of treatment patterns over 12 years from a high volume centre for focal therapy

by A. Stabile, G. Gandaglia, N. Fossati, A. Gallina, C.A. Bravi, E. Mazzone, A. Martini, F. Barletta, S. Scuderi, G. Fallara, V. Cucchiara, E. Zaffuto, R. Daniele, F. Pellegrino, C. Orczyk, F. Giganti, H.U. Ahmed, M. Emberton, A. Briganti, F. Montorsi, C.M. Moore
Published 2020-10-01

Anatomical prostate mpMRI features and continence recovery after robot assisted radical prostatectomy: is there something beyond membranous urethral length? results from a large, m...

by M. Tutolo, G. Tasso, G. Stabile, W. Everaerts, S. Joniau, D. De Ridder, F. Van der Aa, L. Bruyneel, B. Van Cleynenbreugel, F. De Cobelli, A. Esposito, D. Cannoletta, V. Cucchiara, E. Zaffuto, V. Mirone, A. Salonia, N. Fossati, G. Gandaglia, F. Montorsi, A. Briganti
Published 2020-10-01

Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era?

by F. Pellegrino, A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, F. Barletta, S. Scuderi, V. Cucchiara, D. Robesti, A. Rizzo, E. Mazzone, G. Rosiello, C.A. Bravi, R. Leni, M. Moschini, G. Brembilla, A. Esposito, P.I. Karakiewicz, F. Montorsi, F. De Cobelli, A. Briganti
Published 2020-10-01

The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with ol...

by E. Mazzone, A. Heidenreich, G. Gandaglia, D. Pfister, S. Shariat, B. Grubmuller, N. Fossati, A. Stabile, S. Scuderi, F. Pellegrino, G. Sorce, G. Fallara, G. Rosiello, A. Martini, M. Bandini, V. Cucchiara, E. Zito, A. Pellegrino, P.I. Karakiewicz, M. Moschini, R.J. Karnes, F. Montorsi, A. Briganti
Published 2020-10-01

Should we target all visible areas at mp-MRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series

by A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, F. Barletta, S. Scuderi, V. Cucchiara, L. Nocera, E. Zaffuto, F. Scalvi, D. Robesti, D. Cannoletta, E. Zito, M. Menean, E. Mazzone, P. Dell’Oglio, A. Salonia, P.I. Karakiewicz, F. Montorsi, F. De Cobelli, A. Briganti
Published 2020-07-01

The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer

by D. Cannoletta, G. Gandaglia, D. Pfister, S. Shariat, B. Grubmuller, N. Fossati, A. Stabile, S. Scuderi, F. Pellegrino, G. Sorce, G. Fallara, A. Martini, V. Cucchiara, D. Robesti, A. Rizzo, F. Scalvi, A. Gallina, E. Mazzone, P.I. Karakiewicz, R.J. Karnes, F. Montorsi, A. Briganti, A. Heidenreich
Published 2020-10-01

A positive PSMA PET/CT Predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy

by L. Nocera, G. Gandaglia, N. Fossati, V. Cucchiara, D. Robesti, F. Barletta, S. Scuderi, A. Rizzo, E. Zito, A. Gallina, E. Camisassa, L. Sciacqua, M. Droghetti, G. Sorce, F. Pellegrino, E. Mazzone, A. Stabile, C.A. Bravi, A. Martini, P.I. Karakiewicz, M. Moschini, F. Montorsi, A. Briganti
Published 2020-10-01

Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance: Results from a single institution ser...

by M. Bandini, L. Nocera, A. Stabile, R. Leni, G. Gandaglia, N. Fossati, N. Suardi, V. Cucchiara, F. Barletta, D. Cannoletta, E. Camisassa, S. Comana, L. Sciacqua, M. Droghetti, G. Rosiello, E. Mazzone, M. Tutolo, C. Bravi, A. Mottrie, M. Moschini, V. Mirone, N. Longo, F. Montorsi, A. Briganti
Published 2020-07-01

The relationship between percentage PSA reduction and rate of failure after focal therapy for prostate cancer

by A. Stabile, G. Gandaglia, N. Fossati, C. Orczyk, F. Giganti, S. Scuderi, V. Cucchiara, D. Robesti, E. Zaffuto, F. Barletta, G. Sorce, F. Pellegrino, M. Moschini, N. Cathala, P. Macek, H.U. Ahmed, M. Emberton, X. Cathelineau, A. Briganti, F. Montorsi, R. Sanchez-Salas, C.M. Moore
Published 2020-07-01

The relationship between percentage PSA reduction and rate of failure after focal therapy for prostate cancer

by G.O. Cirulli, A. Stabile, G. Gandaglia, N. Fossati, C. Orczyc, F. Giganti, S. Scuderi, V. Cucchiara, D. Cignoli, E. Zaffuto, F. Barletta, F. Pellegrino, E. Vecchio, M. Moschini, N. Cathala, P. Macek, H.U. Ahmed, M. Emberton, X. Cathelineau, A. Briganti, F. Montorsi, R.Sanchez Salas, C.M. Moore
Published 2020-10-01

Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches

by F. Barletta, A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, G.O. Cirulli, G. Basile, V. Cucchiara, D. Robesti, M. Menean, G. Rosiello, C.A. Bravi, P. Dell’Oglio, A. Martini, A. Salonia, L. Sciacqua, G. Brembilla, A. Esposito, F. Montorsi, F. De Cobelli, A. Briganti
Published 2020-10-01

A positive PSMA PET/CT predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy

by D. Robesti, G. Gandaglia, N. Fossati, V. Cucchiara, L. Nocera, F. Barletta, S. Scuderi, A. Rizzo, E. Zito, A. Gallina, E. Camisassa, L. Sciacqua, D. Santangelo, M. Droghetti, G. Sorce, F. Pellegrino, E. Mazzone, A. Stabile, C.A. Bravi, A. Martini, P.I. Karakiewicz, M. Moschini, F. Montorsi, A. Briganti
Published 2020-07-01

Are men with low risk prostate cancer but high PIRADS score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatecto...

by A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, F. Barletta, S. Scuderi, V. Cucchiara, G. Fallara, D. Robesti, D. Cannoletta, S. Comana, F. Pellegrino, E. Mazzone, G. Rosiello, C.A. Bravi, P. Dell’Oglio, A. Salonia, G. Brembilla, A. Esposito, F. Montorsi, F. De Cobelli, A. Briganti
Published 2020-07-01